NewMediaWire | REMSleep 510K Submission

Condensation testing per ISO
18562-4 :2017

Tampa, FL – (NewMediaWire) – October 28, 2021 – REMSleep
Holdings, Inc. (OTC PINK: RMSL): The company has been advised by the FDA after considerable
correspondence that additional testing is required for its 510K
submission.  Remsleep is proceeding with the testing as soon as possible.

Proceeds from Reg A will be
used for additional product development, expected new patent application(s),
aggressive marketing, product inventory after 510K approval.

Forward-looking statements.

Some statements in this release
may contain forward-looking information. All statements, other than of
historical fact, that address activities, events or developments that the
Company believes, expects or anticipates will or may occur in the future
(including, without limitation, statements regarding potential acquisitions and
financings) are forward-looking statements. Forward-looking statements are
generally identifiable by use of the words “may”, “will”,
“should”, “continue”, “expect”,
“anticipate”, “estimate”, “believe”,
“intend”, “plan” or “project” or the negative of
these words or other variations on these words or comparable terminology.
Forward-looking statements are subject to a number of risks and uncertainties,
many of which are beyond the Company’s ability to control or predict, that may
cause the actual results of the Company to differ materially from those
discussed in the forward-looking statements. Factors that could cause actual
results or events to differ materially from current expectations include, among
other things, without limitation, the inability of the Company to obtain
sufficient financing to execute the Company’s business plan; competition; regulation
and anticipated and unanticipated costs and delays, and other risks disclosed
in the Company’s public disclosure record on file with the relevant securities
regulatory authorities. No information in this press release should be
construed as any indication whatsoever of the Company’s future revenues,
results of operations or stock price. Although the Company has attempted to
identify important factors that could cause actual results or events to differ
materially from those described in forward-looking statements, there may be
other factors that cause results or events not to be as anticipated, estimated
or intended. Readers should not place undue reliance on forward-looking
statements. The forward-looking statements included in this news release are
made as of the date of this news release and the Company does not undertake an
obligation to publicly update such forward-looking statements to reflect new
information, subsequent events or otherwise unless required by applicable
securities legislation.

Tom Wood